Opsonophagocytosis machinery

Opsonophagocytosis machinery refers to the integrated biological system responsible for the recognition, engulfment, and destruction of pathogens that have been tagged by opsonins, specifically complement proteins like C3b and iC3b (StatPearls, 2023). This process is a cornerstone of the innate immune response, bridging the gap between complement activation and cellular clearance by professional phagocytes such as neutrophils and macrophages (Janeway's Immunobiology, 2017). The machinery relies on the interaction between opsonized pathogens and specific cell-surface receptors, including Complement Receptor 1 (CR1) and Complement Receptor 3 (CR3), which trigger cytoskeletal rearrangements and phagosome formation (Nature Reviews Immunology, 2016). In clinical practice, this system is a focal point for treating severe infections and autoimmune disorders; for instance, intravenous immunoglobulin (IVIG) can provide exogenous opsonins to enhance clearance (Journal of Clinical Immunology, 2019). Conversely, complement inhibitors like pegcetacoplan target C3 to prevent excessive opsonization in diseases like paroxysmal nocturnal hemoglobinuria (NEJM, 2021). Deficiencies in any component of this machinery lead to profound immunodeficiency and recurrent infections with encapsulated bacteria. Consequently, while not a single molecular target, the opsonophagocytosis machinery represents a critical pathway for therapeutic modulation in infectious and inflammatory contexts.

Other names

Complement-mediated opsonophagocytosisOpsonization-dependent phagocytosisComplement-dependent cellular phagocytosisComplement-opsonized pathogen clearance

The machinery is modulated by drugs that either provide exogenous opsonins (e.g., IVIG, monoclonal antibodies) to facilitate pathogen clearance or inhibit complement components (e.g., C3 or C5 inhibitors) to prevent opsonin deposition and subsequent phagocytosis-mediated tissue damage.